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1. Introduction 
Urinary tract infections (UTIs) and their complications represent one of the most common 
causes of medical consultation with high cost to medical services and high morbidity and 
mortality. Urinary stones are another medical challenge that represents an acute or chronic 
clinical setting for patients requiring most of the time active treatment, either as an invasive 
or as a non-invasive management, thus increasing costs and risks. The combination of both 
clinical scenarios —urinary tract infection and urinary stone— is common and can trigger a 
systemic inflammatory response syndrome (SIRS) before, during or after medical treatment 
(i.e. antibiotics) and/or surgical manipulation of infected urinary stones. It is believed that 
SIRS is due to the release of endotoxins from infected urinary stones, developing 
endotoxemia, bacteremia and urosepsis. If not controlled, multiple organ failure syndrome 
(MOF) and death of the patient may occur. Urologists are familiar with these scenarios 
where not only prevention and diagnosis but also an early and appropriated treatment is 
crucial. Unfortunately, the use of prophylactic antibiotics does not guarantee prevention of 
these fatalities. The aim of this chapter is to review the evidence of possible endotoxin 
release during invasive and non-invasive treatment of infected urinary stones as a trigger of 
SIRS and sepsis. 
2. Urinary tract infections 
Urinary tract infections are the second most frequent infections in developed countries and 
uropathogenic Escherichia coli (E. coli) a non-urea-splitting bacterium represents 80 % of 
uncomplicated UTIs (Oelschlaeger et al., 2002). There is a geographic variation about E. coli 
and several other Gram-negative, as well as Gram-positive bacteria and fungi causing 
complicated and uncomplicated UTIs among specific populations. Virulence of bacteria 
causing UTIs is determinant for progression of the disease. Some virulence factors in 
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uropathogenic E. Coli, as adhesins (Type 1 pili, Dr-family pili, P fimbriae, F1C fimbriae, S 
fimbriae) and toxins (CNF1, Hemolysin and Sat)  (Oelschlaeger et al., 2002), could explain 
the systemic forms of invasion of the bloodstream by some Enterobacteriaceae in possible 
synergism with the release of endotoxins that may result in SIRS and urosepsis. These 
virulence factors are reviewed elsewhere in this book. 
2.1 Urinary bacterial epidemiology 
Urinary tract infections in Western countries are mainly caused by E. coli (90 %), Proteus spp, 
Klebsiella spp, and Pseudomonas spp (McRae & Shortliffe, 2000; Bochud & Calandra, 2003). 
Variation in proportions and specific populations have been reported and described 
(Foxman, 2003; Savas et al., 2006). Bacterial resistance is another important issue that 
increases morbidity and mortality. For further details and specific information about 
bacterial epidemiology in UTIs we invite the reader to consult other sections of this book. 
2.1.1 Endotoxins 
To invade hosts, bacteria use a variety of substances, some of them are essential for their 
survival. In Gram-negative bacteria, specific molecular patterns composed of lipid and 
sugar moieties represent some of the most toxic virulence factors of bacterial origin. 
Structurally classified as lipopolysaccharides (LPS), these substances have no chemical 
homologs among human cells, and are known as endotoxins, to denote their ability for 
causing fever, shock and organ injury when released in mammalian endothelial vessels 
(Beutler, 2000). The presence of endotoxins in the blood-stream is named endotoxemia and 
can trigger SIRS. LPS have specific structural motifs which are typical of different bacterial 
species. However, all of them are known to induce endotoxemia and sepsis (Bochud & 
Calandra, 2003). Endotoxins are known to be recognized by cell-surface proteins, the LPS 
receptors, which are widely distributed in animals as part of their immune systems (from 
insects to vertebrates). However, a strong inflammatory reaction after LPS recognition is 
restricted to a handful of species, including humans (Beutler, 2000). According to numerous 
studies in cellular and animal models, recognition of LPS by their receptors initiate a 
cascade of intracellular signals guiding the secretion of pro-inflammatory mediators 
(Beutler, 2000; Triantafilou & Triantafilou, 2005). An emerging concern is the toxicity of LPS 
after microbial death, especially in the context of hospital-acquired infections. In fact, 
released LPS keep their full toxic potential, unless inactivation processes take place in the 
host to degrade endotoxins (Munford et al., 2009). 
3. Urinary stones 
Urinary stones have been reported in human history since antiquity. Traditionally, stones 
have been classified according to their main mineral content. The etiology of urinary stones 
is wide, including chronic dehydration, urinary tract malformations, obstructed uropathy, 
metabolic diseases (i.e. hyperparathyroidism, gout, and obesity), foreign body inside 
urinary tract, infections, etc. The risk for stone disease in patients of developed countries is 
close to 10 % life-long. An increase in the incidence of stone disease related with changes in 
the life style, modifications on the diet, morbid obesity surgery syndrome and new drugs 
has been reported in Western countries in recent years. For example, in the United States, an 
increase of 37 % in stone disease was observed over the last 20 years (Straub & Hautmann, 
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2005). A variation in the frequency and in the composition of the minerals forming the 
urinary stones was also observed. 
There is a large variety of urinary stone compositions. If the main component is more than 
80 % of the total mass, the stone is named “pure”. If the main component is at least 50 % of 
the stone, it is named mixed. In Western countries, struvite stones used to represent 15-30 % 
of cases. Nowadays only 2 % of stones are struvite (McALeer et al., 2003; Kramer et al., 
2000). The explanation of that decrease is unknown. In developing countries and Eastern 
countries there is a large variation among incidence, prevalence and stone composition. For 
example, in India a report including 1050 urinary calculi from surgically treated patients 
(900 renal and 150 ureteral) revealed 93.04 % oxalate calcium stones (80 % calcium oxalate 
monohydrate [COM] and 20 % calcium oxalate dihydrate [COD]), 1.92 % struvite stones, 
1.48 % apatite stones, 0.95 % uric acid stones and 2.96 % mixed stones. Surprisingly, 89.98 % 
of the staghorn stones consisted of oxalates and only 4.2 % were struvite (Ansari et al., 2005). 
A study in Japan showed that the most common stone composition was struvite (32.1 %) 
and mixed calcium oxalate phosphate (22.2 %) (Akagashi et al., 2004). These differences 
could be explained by variations in ethnics, epigenetics, geographical area, diet, life-style, 
and different metabolism.  
3.1 Infected stones 
It has been suggested that urinary stones can be infected mainly in two ways. Stones 
develop due to several mechanisms which may or may not be associated to obstructive 
uropathy (i.e. hyperparathyroidism). The first way in which a stone can be infected is by 
ascending bacteria. Once the stone is formed, ascending bacteria may reach its surface, 
invade the interstice and become part of it (Takeuchi et al., 1984; Abrahams & Stoller, 2003). 
Adherence of new minerals could cover and paste bacteria layers. In this case, the stone acts 
as a reservoir for bacteria. Due to the poor penetration of drugs into the stone matrix the 
action of antibiotics is limited (Prabakharan et al., 1999). This phenomenon can be the reason 
of bacterial resistance, repeated, chronic or complicated UTIs in several patients, therefore 
increasing the risk of urosepsis. The most possible scenario according to the most frequent 
stone component and urinary bacteria in our Western world is a calcium stone infected with 
E. coli. In this case, the urinary stone forms first and gets infected by bacteria afterwards.   
The second scenario is that bacteria living inside the urinary tract and causing chronic UTIs 
produce the stones. These bacteria are named urea-splitting bacteria. Members of this group 
are Proteus, Klebsiella, Pseudomonas, Providencia, Serratia spp, Staphylococcus aureus and 
Ureaplasma urealyticum, among others. P. mirabilis accounts for more than half of all urease-
positive urinary infections (Kramer et al., 2000). Urea-splitting bacteria change the urine pH 
(> 7.2) and allow easier precipitation of phosphate with several compounds, mainly 
ammonium and magnesium (Abrahams & Stoller, 2003). The result is a compound 
phosphate named struvite (magnesium-ammonium-phosphate [MAP] stones and/or triple 
phosphate stones). Another type of phosphate stones are apatite stones (calcium phosphate). 
The terms “infectious stones” or “infection stones” are used as synonymous of struvite 
stones and represent up to 15 % of all stones sent for analysis in the Western world (Kramer 
et al., 2000).  Infected stones that contain struvite may originate de novo, but often pre-
existing stones are infected with urea-splitting bacteria (Kramer et al., 2000). There is 
evidence that urinary tract infections caused by urease-producing microorganisms are not 
exclusively related to the formation of struvite stones. Considering this scenario, Proteus 
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mirabilis and struvite stones are the most likely combination. In this case, the risk for 
urosepsis is also patent.  
It has been suggested that some agents named nanobacteria could have a role in the 
development of calcium-based urinary stones (Kajander & Çiftçioglu, 1998); however, this  
is not yet well established (Kramer et al., 2000).  A prevalence of nanobacteria in 0.5 % of 
1000 stones was reported; but nanobacteria are still difficult to identify (Abrahams & Stoller, 
2003). 
3.1.1 Bacterial epidemiology of infected urinary stones 
Urinary stone cultures from fragments retrieved during stone surgery were not a common 
practice until recently. Negative urine culture before urinary surgery was considered safe. In 
general urology it has been a routine to have a negative midstream urine culture before 
doing any endoscopic procedure. Recent studies suggest that voiding urine culture is not 
representative of upper urinary tract pelvis infection or pelvis infected stone bacteria 
(Mariappan & Loong, 2004; Mariappan et al., 2005a). A group of 73 patients with unilateral 
stone-obstructed ureter were treated with ureterorenoscopy and lithotripsy. Midstream 
urine (MSU) sample culture and sensitivity were performed the morning of the endoscopic 
surgery. During the procedure a pelvis urine sample and stone fragments were collected for 
culture and sensitivity with an aseptic technique in a retrograde approach. The authors 
reported that 25 (34.3 %) patients had positive stone culture, 43 (58.9 %) had positive pelvic 
urine and 21 (28.8 %) had positive MSU culture. The most common isolated bacterium was 
E coli. The MSU culture and sensitivity test had 30.2 % sensitivity and 73 % specificity to 
detect pelvic urine culture and sensitivity. The same test had a low positive predictive value 
and negative predictive value in relation to infected pelvic urine (positive predictive value = 
0.62, negative predictive value = 0.42) (Mariappan & Loong, 2004). According to these 
authors, in case of a ureteral obstructive uropathy secondary to a stone, MSU culture and 
sensitivity do not represent infected urine proximal to the obstruction or infected stone. 
Stone components were not analyzed. In conclusion, pelvic urine and stone cultures were 
considered as a more appropriate indicator of upper urinary tract infection. Collection of the 
obstructed urine for culture and sensitivity are recommended.          
Mariappan and colleagues (2005a) studied a group of 54 patients with renal stones who 
were candidates for percutaneous nephrolithotomy (PCNL). Various specimens were 
collected for culture and sensitivity, i.e., MSU sample, bladder urine sample, renal pelvic 
urine sample and crushed stone sample. The objective of the study was to identify the most 
predictive analysis of urosepsis. MSU culture was positive in 11.1 % of cases, stone culture 
was positive in 35.2 % and pelvic urine was positive in 20.4 % of cases.  A wide variety of 
bacteria were isolated. In 37 % of the patients SIRS was developed and 5.5 % experienced 
septic shock. Pelvic urine culture predicted infected stones better than bladder urine culture. 
Patients with infected stones or pelvic urine were found to be at a relative risk for urosepsis 
that was at least four times greater (P = 0.0009). The authors concluded that positive stone 
and pelvic urine are better predictors of potential urosepsis than bladder urine and 
recommend routine collections of these specimens. Stone components were not analyzed. 
The bacterial epidemiology of infected urinary stones also depend on differences in 
geographic area, strains, bacterial resistance, bacterial virulence, exposure to some kind of 
antibiotics and environment.   
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4. Sepsis and urosepsis 
Sepsis is an extreme health condition that threatens life of patients with a high cost for the 
healthcare systems. Reports from US and European surveys have estimated that severe 
sepsis accounts for 2–11 % of all admissions to hospitals or intensive care units. The most 
common microbes isolated from patients with severe sepsis and septic shock are Gram 
negative bacilli (mainly E. coli, Klebsiella species and Pseudomonas aeruginosa) and Gram 
positive cocci (mainly Staphylococci and Streptpcocci spp). Most cases of Gram negative sepsis 
are caused by E coli and Klebsiella species followed by P. aeruginosa. Infections usually occur 
in the lung, abdomen, bloodstream, or urinary tract (Bochud & Calandra, 2003).  In a trial 
performed in an intensive care unit with 142 septic patients having a urinary catheter, 
urosepsis occurred in 15.8 % of them (Rosser et al., 1999). Urosepsis in adults comprises 
approximately 25 % of all sepsis cases and in most cases is due to complicated urinary tract 
infections (Wagenlehner et al., 2007). An incidence of sepsis associated with obstructed 
uropathy and urinary stones treated surgically has also been reported in 1.28 % of cases 
(O'Keeffe et al., 1993).  Rao et al. (1991) found an incidence of septic shock after endoscopic 
manipulation for urinary stone in about 1% of treated patients. Sepsis is an advanced stage 
of uncontrolled systemic inflammatory response syndrome that may turn toward 
irreversible multiple organ failure and death. 
5. Endotoxins and sepsis 
Activation of local and systemic metabolic response to trauma and SIRS is mainly caused by 
activation of IL-1 and tumor necrosis factor-α (TNF-α). It is well established that after 
recognition by cognate receptors, LPS trigger the synthesis and release of pro-inflammatory 
cytokines (Triantafilou & Triantafilou, 2005). Once IL-1 and TNF are secreted, they activate 
several other reactions like complement factors, exacerbating the host inflammatory 
response. As a consequence, MOF or death may result. In vitro human blood monocytes 
produce IL-1 and TNF-α when they are exposed to 25 to 50 pg/mL of endotoxin 
concentration. These endotoxin levels have been reported in the bloodstream of patients 
during septic shock (Dinarello & Cannon, 1993). In a clinical report of 97 consecutive 
patients, 56 % developed sepsis syndrome with about 26 pg/mL  of TNF-α.; 37 % had 20 
pg/mL of IL-1 and in 80 %, 415 pg/mL of IL-6 was detected, including a LPS mean 
concentration of 2.6 endotoxin units (EU)/mL (1 EU/mL = 0.6 ng/mL) (Casey et al., 1993). 
The level of procalcitonin has also been used as a sepsis marker. Another assay with healthy 
volunteers demonstrated elevation of procalcitonin (peak up to about 4 ng/mL at 6 hours) 
after I.V. administration of 4 ng/kg of body weight of endotoxin derived from E coli 
0113:H10:k (Dandona et al., 1994). In a new human model of low grade inflammation, 10 
healthy male subjects were exposed to 3 ng/kg body weight of endotoxin (LPS) derived 
from E. coli in I.V. bolus injection versus I.V. infusion during 4 hours. Results revealed that 
TNF-α, IL-6 and neutrophil response were earlier and more pronounced in the bolus trial, 
suggesting that sudden release of endotoxins triggers faster and higher release of cytokines 
and inflammatory mediators similar to sepsis. Changes in cytokines measured in the 
infusion trial would be a more representative model of human systemic low-grade 
inflammation in chronic disease (Taudorf et al., 2007). 
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6. Infected urinary stones and urosepsis 
In a study on 700 patients, the prevalence of sepsis related with obstructed uropathy and 
urinary stones treated surgically was 1.28 %. These nine patients developed SIRS and sepsis 
during 6 hours postoperative. Although males and females were treated in roughly equal 
proportions, all of the patients who developed severe sepsis were females. There were six 
deaths accounting for 66 % mortality (O'Keeffe et al., 1993). Septic shock following urinary 
stone manipulation was reported with an incidence of 1 % and mortality up to 80 % (Rao et 
al., 1991). 
In an effort to predict septicemia following endourological manipulation for stones in the 
upper urinary tract, 117 patients were studied and classified according to the procedure 
performed (Rao et al., 1991): Percutaneous nephrolithotomy, push-back/push-bang 
procedure, double-J and extracorporeal shock wave lithotripsy (SWL), ureteroscopy, SWL 
alone and only cystoscopy. Blood samples for bacterial culture, endotoxin and tumor 
necrosis factor assay were collected before, at onset, at the end and one hour after 
completing the procedure. Preoperative bacteriuria was present in 35 % of the patients. The 
mean endotoxin level of the entire group —except the cystoscopy group— was 16.2 pg/mL 
(range 11 to 58.3 pg/mL). In the cystoscopy group the mean endotoxin level was 11.7 
pg/mL (range 11 to 12.2 pg/mL). All patients (16) with preoperative endotoxemia had 
increased levels of endotoxin detected in subsequent samples (mean increase 15 pg/mL, 
range 0.5 to 64 pg/mL). The tumor necrosis factor was greater than 15 pg/mL in four cases 
preoperatively. Postoperatively there was elevation of the tumor necrosis factor only in 12 
patients. The authors reported that in case of upper urinary tract manipulation, the risk of 
bacteremia was higher. The risk was greatest after performing the push-back method and 
least after cystoscopy. Combination of preoperative endotoxemia, bacteriuria and the type 
of procedure had 85 % of sensitivity, 84 % of specificity and a positive predictive value of 52 
% for the development of postoperative bacteremia. A total of 41 patients had pyrexia and 
17 patients had rigors and fever 2 to 3 hours after the end of the procedure. No patient 
suffered septic shock; however, this complication developed in a female patient one week 
after percutaneous nephrolithotomy. Serum endotoxin and tumor necrosis factor levels after 
admission of this patient to the intensive care unit were 67.7 pg/mL and 3,827.5 pg/mL, 
respectively (Rao et al., 1991). 
Measurements of LPS were done in 34 renal stones, stored for several months and classified 
as infection stones (16), i.e., struvite and calcium apatite, and non-infection stones (18) 
composed of 50 % calcium oxalate monohydrate (McALeer et al., 2003). All stones were 
weighed, aseptically crushed and aliquots were tested for endotoxins. Four stones of each 
group were aseptically washed and crushed separately. Washed materials and crushed 
stones were processed in MacConkey agar culture to recover bacteria colonizing the stones. 
Mean endotoxin concentration in the infection group was 12,223 ng per gram of stone and 
340.3 ng per gram of stone in the non-infection group. The difference was statistically 
significant (P = 0.001). These results reveal an almost 36 times higher concentration of 
endotoxins in the infection stones. No living bacteria were recovered on the MacConkey 
plates from crushed stones from neither group. The authors concluded that large amounts of 
endotoxins can be found in infected renal stones even months after they were removed from 
the body, and long after viable bacteria could be detected. Furthermore, endotoxin may 
remain after bacteria are no longer viable or have been killed with antibiotic therapy 
(Munford et al., 2009).  Non-infectious stones can also contain endotoxin but in a lower 
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amount (McALeer et al., 2003). McALeer et al. (2002) published a case report of an 8 year old 
boy with a left staghorn calculus treated with holmium laser percutaneous 
nephrolithotripsy (PCNL). Culture specific antibiotic were administered to the patient, both 
orally and intravenously, before, during and after surgery.  Intraoperative fluid and pleural 
fluid cultures (urologists lost percutaneous access from lower pole calyx with 
intraperitoneal extravasation and pleural effusions) were obtained. A urine culture was 
performed before and after stone manipulation. All samples grew a few colonies of Proteus 
mirabilis. Blood cultures were requested but could not be obtained; serum endotoxin results 
could not be obtained either. Two hours after procedure the patient developed disseminated 
intravascular coagulopathy. Twelve hours after stone manipulations the patient died despite 
aggressive support care. Stone composition was apatite (80%) and struvite (10%). Post-
mortem culture of the stone grew several colonies of Proteus mirabilis.  The assay of the stone 
fragments for endotoxin showed concentrations of 285,600 pg per gram, suggesting that 
endotoxemia can induce sepsis syndrome without concomitant bacteremia. The authors 
concluded that the outstanding endotoxin concentration of the renal stone was the source of 
the fatal outcome. 
There is not a general consensus on how to best prevent sepsis in patients undergoing 
surgical treatment of urinary stones. Pre-surgical, trans-surgical and post-surgical strategies 
have been proposed. The combination of multiple factors can prevent, trigger or worsen 
sepsis. For example, control of metabolic or cardiopulmonary diseases is important. 
Although antibiotic prophylaxis does not completely avoid the risk of developing sepsis, it 
is a recommendation for stone surgery according to the American Urological Association 
(AUA) and the European Association of Urology (EAU) guidelines on urinary tract infection 
(Grabe et al., 2011; Wolf et al., 2010). It is suggested to define an antibiotic prophylaxis 
according to local bacterial populations, resistance and antibiotic sensitivity patterns. In a 
prospective controlled trial, Mariappan et al. (2006) and Bag et al. (2011) reported the 
beneficial use of one week ciprofloxacin and nitrofurantoin regimen respectively, before 
percutaneous nephrolithotomy. Furthermore it has been found that renal stones larger than 
20 mm are more likely to be culture positive (Mariappan et al., 2005a; 2005b). Mariappan 
and colleagues (2005a) suggested to obtain pelvic urine and stone samples for culture and 
sensitivity as a routine during surgical stone procedures, with the aim of administering 
proper antibiotic regimen if later urosepsis develops. If an unusual urine sample (i.e. 
turbidity, foully) is obtained, culture and sensitivity is a must. In this case, a nephrostomy 
tube should be left in place and the initial procedure rescheduled until sterile urine is 
confirmed. 
An increase of pressure inside the urinary tract system generated by the irrigation fluid 
results in a potential bacterial and endotoxin translocation into the bloodstream. Auge et al. 
(2004) reported significant reduction in urinary tract pressures using ureteral access sheath 
if working both in distal ureter and inside the renal pelvis. Bacteria and likely endotoxins 
may emerge from several kinds of urinary stones and not exclusively from struvite stones 
(Hugosson et al., 1990; McALeer et al., 2003). In post-surgical stage, the most critical 
evidences of SIRS are during the first 6 hours post-procedure and seem to correlate with 
cytokines release into the bloodstream after endotoxin stimulus (Dandona et al., 1994; 
O'Keeffe et al., 1993; Rao et al., 1991; Taudorf et al., 2007). It has been suggested that if other 
causes of SIRS different than infection (i.e. cardiogenic or pulmonary events, atelectasis, 
hypovolemia and pain) have been ruled out and if SIRS persists, then sepsis could be the 
explanation (Monga, 2005). Close vital signs and symptoms monitoring and high suspicious 
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index for sepsis is crucial at this stage. Once urosepsis is diagnosed, an early tissue 
oxygenation, appropriate initial antibiotic therapy, inotropic and nutritional support with 
invasive monitoring at intensive therapy unit is required. Empirical broad-spectrum 
antibiotics regimen is prescribed according to local bacteria, sensitivity and resistance 
patterns. If cultures were performed from bladder urine, pelvis urine or stone sample, direct 
therapy must be installed as soon as results are obtained (Mariappan et al., 2005b). 
Wagenlehner and his group (2007) reported that the treatment of urosepsis comprises four 
major aspects: Early goal-directed therapy, optimal pharmacodynamics exposure to 
antimicrobials both in blood and in the urinary tract, control of complicating factors in the 
urinary tract and specific sepsis therapy.  They considered that interdisciplinary approach is 
necessary to achieve an optimal goal of treatment. At any of these stages, it is very 
important to act as soon as possible if any evidence of initial SIRS and urosepsis is 
addressed. It is necessary to instruct the patient and relatives once discharged from the 
hospital, that if SIRS develops, urgent evaluation in an emergency unit is crucial (Rao et al., 
1991). There is no doubt that further research is required and that several other issues have 
to be considered; however, these do not fall within the scope of this chapter. 
7. Research on bacterial suspensions and extracorporeal shock wave 
lithotripsy 
Several articles report the bactericidal effect of shock waves in vitro; however, results remain 
controversial. Elbers et al. (1988) observed no effect of shock waves on calculi inoculated 
with urease-positive calculogenic bacteria. Bacteria from different genera and species have 
different resistances to physical, chemical and environmental factors; such variations in 
bacteria may determine the degree of susceptibility to shock waves. For instance, we have 
previously found that shock wave-induced cavitation contributes to L. monocytogenes, S. 
typhimurium and E. coli O157:H7 inactivation; however, L. monocytogenes was more sensitive 
to shock waves than E. coli O157:H7 (Alvarez et al., 2004). Kerfoot and colleagues (1992) 
found no effect of shock wave application on S. aureus; however von Eiff et al. (2000) 
reported inactivation of a different strain of the same bacteria.  Similarly, whereas Ohshima 
et al. (1991) observed no effect of shock waves on the viability of E. coli strains DSM 1077 
and JM 109/pKPDH2, Loske et al. (1999) reported inactivation of E. coli strain ATCC 10536. 
Patel et al. (2005) reported no effect of shock waves on a five-stain cocktail of E. coli 
O157:H7, whereas Podolak et al. (2005)  reported shock wave inactivation of a slightly 
different cocktail of the same E. coli. Various shock wave generators were used by these 
authors, which may explain their different results. When performing in vitro exposure of 
bacteria in suspension by shock waves generated with electrohydraulic shock wave 
generators, the electromagnetic radiation produced at the spark gap contributes to 
microorganism inactivation. During SWL this radiation (visible and UV) does not penetrate 
into the calculus. Besides, electromagnetic radiation, compression, tensile stress, and 
cavitation may also damage bacteria. Cavitation is produced by the trailing tensile pulse of 
the shock wave. A cloud of bubbles forms at the focus of every lithotripter after the passage 
of each shock wave. During collapse, they create secondary shock waves, powerful jet blasts 
of fluid (microjets), high temperature gradients, and free radicals (Crum, 1988). If a second 
shock wave is sent during, or shortly after, the stable phase of the bubbles, their collapse can 
be intensified. This technique, referred to as “tandem SWL” has proven to reduce in vivo 
SWL treatment time by 50 % (Fernández et al., 2009). To test the efficiency of tandem shock 
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waves to inactivate bacteria, Alvarez and colleagues (2008) used an experimental 
piezoelectric tandem shock wave generator that generates two shock waves shifted in time. 
The effects of single and tandem shock waves on the viability of L. monocytogenes and E. coli 
O157:H7 suspensions were studied. Tandem shock waves were generated at delays of 450 
and 900 microseconds. No effect on bacteria viability was reported after exposure to 8,000 
single shock waves, but significant bacteria inactivation was reported after 3,400 tandem 
shock waves. The delay yielding the highest inactivation was 900 microseconds.  
8. Research with stone models 
Efforts to develop an ideal stone model have been done worldwide to perform in vitro and 
in vivo fragmentation tests exposing artificial stone models to different lithotripter energy 
settings. To study the inactivation of bacteria by shock waves and the bactericidal effect of 
different intracorporeal lithotripters, we developed an artificial calcium sulphate stone 
model infected homogenously with E. coli, a mixed struvite-calcium sulphate stone infected 
with P. mirabilis and a calcium sulphate stone infected with P. mirabilis. 
8.1 The bactericidal effect of intracorporeal lithotripters 
Only a few authors report results on the interaction of infected urinary stones with 
intracorporeal lithotripters. Artificial kidney stones, infected with E. coli, were manufactured 
by our research group to evaluate the bactericidal effect of shock waves, and the differences 
on intra-bacterial protein release produced by four different intracorporeal lithotripters. The 
stone models were exposed to a holmium laser, an electrohydraulic, a pneumatic and an 
ultrasonic intracorporeal lithotripter using two energy settings. Non-infected control stones 
were manufactured by casting a mixture of gypsum cement, Velmix-stone (Kerr Division of 
Syborn Corp., Romulus, MI, USA) and distilled water in cylindrical molds (diameter = 10 
mm, height = 10 mm). A saline solution containing E. coli was used instead of distilled water 
to manufacture the infected stones.  Cells were obtained in the stationary phase of growth. 
Stones were placed on a copper mesh with 1.8 mm by 1.8 mm openings at the bottom of a 
specially designed lucite test tube. The lucite tube was placed inside a standard laboratory 
test tube, containing 10 mL of saline solution. The tip of the lithotripter was introduced 
inside the lucite tube (see Figure 1). Five infected stones were fragmented with each 
lithotripter at each energy level (low and high) during a fixed time. After treatment all 
remaining stone fragments were crushed with a hand press. The suspension containing 
stone powder and bacteria was centrifuged, serially diluted and incubated on agar plates. 
Viable counts were made by plating on trypticase soy agar supplemented with 0.6 % (w/v) 
yeast extract (TSAY). Bactericidal action was defined as the logarithmic difference of colony 
forming units (CFU) per milliliter between untreated and treated stones. To study the effect 
of the lithotripters on bacteria living outside the stone, an E. coli suspension was exposed to 
the action of each lithotripter, using the same energy settings and exposure times as for 
infected stones. The process was repeated five times for each lithotripter at each energy 
setting. Stone fragmentation of infected stones was repeated as described before, in order to 
measure the release of protein (LPS) as a result of in vitro lithotripsy. After treatment, certain 
amount of the suspension was centrifuged and placed inside a spectrophotometer to 
measure absorbance at 280 nm. Results revealed that the variation in the amount of bacteria 
inside the stones was not significant. Complete inactivation resulted with the 
electrohydraulic lithotripter at both energy levels. No difference was observed between 
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inactivation obtained with the other lithotripters at their low energy settings. Increasing the 
energy resulted in higher bacteria inactivation for the laser, pneumatic and ultrasonic 
lithotripter. The laser lithotripter produced the lowest bacteria inactivation. Inactivation 
increased as the energy setting of the laser, pneumatic and ultrasonic lithotripter was 
changed from low to high. No bacteria inactivation was observed using the pneumatic 
lithotripter in an E. coli suspension alone. No viable bacteria could be observed after using 
the laser, the electrohydraulic and the ultrasonic lithotripter in the infected suspension 
(without stone). Maximum protein release occurred at low energy with the electrohydraulic 
lithotripter and protein was denaturized by this lithotripter at the high energy setting. No 
difference was observed between the amount of protein released with the laser, the 
pneumatic, and the ultrasonic lithotripters at both energy levels. The four lithotripters 
inactivated more than 99 % of the initial amount of bacteria; however, this antibacterial 
effect does not necessarily indicate that lithotripters sterilize stone fragments. The presence 
of free endotoxins liberated from bacteria after lithotripsy may increase the risk of sepsis. 
These findings could explain local and systemic inflammation response by the immune 
system of some patients developing in SIRS and sepsis (Gutiérrez et al., 2008). 
 
 
Fig. 1. Photograph of the special lucite test tube with copper mesh bottom (not seen) placed 
inside a standard glass laboratory test tube during in vitro fragmentation of an artificial 
infected kidney stone with a laser lithotripter.  
Our group also studied the effect of the four above-mentioned intracorporeal lithotripters 
on the bacterial inactivation of artificial struvite stones inoculated with Proteus mirabilis. 
Again two energy settings were tested with each lithotripter, with exception of the 
pneumatic lithotripter, which was used only at one intensity. Calcium sulphate stones and 
struvite-gypsum stones were manufactured and homogeneously infected with P. mirabilis. 
Details on the methodology of producing infected stones can be found in the literature 
(Gutiérrez et al., 2008; Gómez-Núñez et al., 2009). Infected calcium sulphate and infected 
struvite-gypsum stones were exposed to each device at each intensity level until complete 
fragmentation. The treatment time was dependant on the lithotripter and the intensity level. 
After in vitro lithotripsy, the suspension containing stone debris and P. mirabilis was diluted 
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and incubated on agar plates. A sham group of non-treated infected stones was crushed 
with a hand press to determine the amount of bacteria surviving inside the artificial stones. 
The whole experiment was repeated three times. The initial viable count in the sham group 
was about 6.02 log10 CFU/mL. Results revealed that all lithotripters inactivated a high 
percentage of P. mirabilis. No statistically significant difference was observed between 
calcium sulphate and infected struvite-gypsum stones (Gómez-Núñez et al., 2009). 
Prabakharan and colleagues (1999) reported an in vitro assay using 46 “natural” struvite 
stone models (fragments), sterilized in an autoclave and reinfected with P. mirabilis, coming 
from patients treated for urinary stones. The stones were exposed to shock waves generated 
with an extracorporeal lithotripter, as well as to the action of an ultrasonic, an 
electrohydraulic, a pneumatic, and a Holium:YAG laser intracorporeal lithotripter. No 
bacterial inactivation was observed, except for the laser intracorporeal lithotripter. A 
possible lack of this trial could be the variability of stone shape, composition, and non-
homogeneous bacteria colonization of the stone. 
In conclusion, it seems that the stone material plays a minor role regarding bacterial 
inactivation due to intracorporeal lithotripsy. Furthermore, according to our results, 
intracorporeal lithotripters are very harmful to bacteria; however, whether bacterial 
destruction is desirable or not is still unknown.  
8.2 The bactericidal effect of extracorporeal lithotripters 
A reduction in bacteriuria and resolution of urinary tract infection after SWL has been 
reported by several authors (Beck & Riehle, 1991; Gerdesmeyer et al., 2005; Michaels et al., 
1988; Pode et al., 1988); however, it is not known if the stone protects bacteria or if other 
mechanisms, such as shear, contribute to the bactericidal effect of shock waves. To answer 
these questions, infected stones were exposed in vitro to shock waves from both an 
electrohydraulic and a piezoelectric lithotripter.  Energy comparable to that used in SWL 
was used, so that the stress on the bacteria was similar to that experienced by bacteria living 
inside calculi during shock wave treatment. Two types of artificial kidney stones (soft and 
hard) were manufactured by mixing different amounts of gypsum cement and Velmix-
stone, as explained in the previous section. In this case the length and diameter of the 
models were about 7 mm and 8 mm, respectively. Salmonella enterica serovar typhimurium in 
the stationary phase of growth was used to inoculate the stones. Stones to be treated were 
placed inside a translucent polypropylene bag, filled with deionized water, heat sealed, and 
centered at the lithotripter focus. All fragments from shock wave treated stones, as well as a 
set of intact control stones, were completely crushed using a hand press until stone powder 
was obtained. All bags were opened and dilutions of the suspension containing stone 
powder and bacteria were inoculated on TSAY plates and incubated at 35 C. About 29 % of 
all bacteria were inactivated with the piezoelectric lithotripter and 14 % with the 
electrohydraulic lithotripter. This study demonstrated that the bactericidal action of shock 
waves is weaker inside the stones than in the fluid outside them (Quintero et al., 2008). 
Whether it is desirable for a lithotripter to inactivate instead of destroying bacteria is still to 
be answered. 
9. Conclusions 
Sepsis is a serious health condition with high mortality and cost. Advances in the 
manufacture of standardized infected stone models and in vitro assays could help to better 
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understand the pathophysiology of sepsis associated to urinary tract infection alone and 
UTIs with infected stones. In vitro fragmentation of artificial stones could also help to 
understand and prevent the pathophysiology and phases of Gram negative sepsis. 
According to our initial results, living bacteria infecting urinary stones release endotoxins as 
part of their metabolic activity or as a consequence of bacteria lysis during intracorporeal 
and extracorporeal lithotripsy. Bacteria fragments could be a source of endotoxin even in the 
case of urine voiding and urine pelvis negative cultures. Further research related with 
release of LPS during lithotripsy and its relation with triggering sepsis is urgently needed. 
Absorption of LPS into the bloodstream by reflux due to open pyelolymphatic and 
pyelovenous channels during obstructive uropathy, bacterial translocation, interaction with 
lithotripters, increased irrigation pressure during endoscopic surgery, and rupture of the 
hemato-urinary barrier (microtrauma) should be studied. On the other hand, recent 
investigations (Soriano et al., 2005; Opal, 2003) have been revealing valuable information 
about sepsis mediators, such as cytokines, including tumor necrosis factor (TNF), 
interferons, complement factors or nitric oxide, anti-LPS host hydrolases, and bacterial 
factors. Translational studies focusing clinical strategies based on benchmark discoveries 
regarding LPS-triggered toxemia therefore represent a major task for the urologist. The main 




 During sepsis, a 25 - 50 pg/mL LPS concentration has 
been reported in the bloodstream.  
 LPS concentrations of up to 285,600 pg per gram stone 
have been reported in a fatal case of urosepsis. 
 Release of LPS has been observed after in vitro 
lithotripsy to infected artificial kidney stones. 
 In vitro application of conventional single-pulse shock 
waves revealed a limited bactericidal effect against 
bacteria in suspension and bacteria inoculated inside 
artificial stones. 
 In vitro application of tandem shock waves to bacterial 
suspensions inactivates bacteria efficiently. 
 In vitro intracorporeal lithotripsy revealed an 
outstanding effect against bacteria in artificial infected 
urinary stones. 
 The bactericidal effect of both extra- and 
intracorporeal lithotripsy should be studied carefully 
due the possible release of large amounts of LPS.     
 Under certain circumstances, this initial evidence 
could explain triggering of SIRS, urosepsis and MOF. 
 
Table 1. Infected Urinary Stones, Endotoxins and Urosepsis. LPS. Lipopolysaccharide; SWL. 
Extracorporeal shock wave lithotripsy; SIRS. Systemic inflammatory response syndrome; 
MOF. Multiple organ failure.  
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